Schonfeld Strategic Advisors LLC Atai Life Sciences N.V. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $918,918 - $1.37 Million	386,100 Added 448.95%	472,100 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $19,468 - $30,194	6,200 Added 7.77%	86,000 $284,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $141,804 - $248,976	46,800 Added 141.82%	79,800 $290,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $153,780 - $252,780	33,000 New	33,000 $168,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $234M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.